Announcement Date Status / Work
Completed
Transaction * Transaction Value
(millions)
March 18, 2019 Pending Advising the Conflicts Committee of the Board of Directors of American Midstream GP, LLC on the merger of American Midstream Partners, LP with an affiliate of ArcLight Energy Partners Fund V, L.P. NA
March 14, 2019 Pending Advising Tee Hai Chem on its joint venture with Brenntag NA
March 14, 2019 Pending Advising Liberty Mutual on its sale of Pembroke Managing Agency and Ironshore Europe DAC businesses to Hamilton Insurance Group NA
March 12, 2019 Closed
March 2019
Advised Hudson Clean Energy Partners on its sale of a stake in Greenlink Interconnector to Partners Group NA
March 8, 2019 Pending Advising the board of RPC Group Plc on the company’s sale to Berry Global Group, Inc. £3,340**
March 6, 2019 Pending Advising Advance Publications on its acquisition of Turnitin from Insight Venture Partners and GIC NA
February 25, 2019 Pending Advising First Reserve on its acquisition of Weir Flow Control from The Weir Group £275
February 25, 2019 Pending Advising TAIT Towers on its investment from funds advised by Providence Equity Partners NA
February 19, 2019 Pending Advising Palo Alto Networks on its acquisition of Demisto $560
February 19, 2019 Pending Advising Targa Resources Corp. on its sale of a 45% interest in Targa Badlands LLC to Blackstone $1,600
February 14, 2019 Closed
February 2019
Advised Avetta on its acquisition of BROWZ NA
February 14, 2019 Closed
February 2019
Advised the Conflicts Committee of EQM Midstream Partners on its agreement with Equitrans Midstream Corporation to exchange and eliminate the EQM Incentive Distribution Rights and restructure the economic general partner interest in EQM ~$3,700
February 13, 2019 Pending Advising Astorg Asset Management on its acquisition of a controlling stake in Anaqua from Insight Venture Partners and Bessemer Venture Partners NA
February 13, 2019 Closed
February 2019
Advised Six Senses Hotels Resorts Spas on its sale from Pegasus Capital Advisors to InterContinental Hotels Group $300
February, 13 2019 Pending Advising Charles River Laboratories on its acquisition of Citoxlab €448
February 12, 2019 Pending Advising Ushr Inc. on its sale to Dynamic Map Platform Co., Ltd. NA
February 7, 2019 Closed
February 2019
Advised the restructuring sub-committee of the restructuring committee of the board of directors of Sears on the sale of substantially all of the company’s assets to Transform HoldCo, an affiliate of ESL investments $5,200
January 30, 2019 Pending Advising Petrobras America Inc. (PAI) on its sale of Pasadena Refining System Inc. and additional related PAI subsidiaries to Chevron U.S.A., Inc. $562
January 24, 2019 Pending Advising MedicX Fund Limited on its all-share merger with Primary Health Properties PLC ~£400
January 16, 2019 Pending Advising the independent directors of the board of First Data Corporation on the company’s sale to Fiserv, Inc. ~$38,800
January 15, 2019 Closed
February 2019
Advised AppRiver on its sale to Zix Corporation $275
January 14, 2019 Pending Advising Vista Equity Partners on its acquisition of a majority stake in Quick Base NA
January 11, 2019 Closed
March 2019
Advised Flybe Group PLC on its sale to Connect Airways Limited, a joint venture owned by Virgin Atlantic, Stobart Group, and Cyrus Capital Partners NA
January 11, 2019 Closed
March 2019
Advised Flotek Industries, Inc. on the sale of Florida Chemical Company, LLC to Archer Daniels Midland Company $175
January 10, 2019 Closed
February 2019
Advised SemGroup’s Board of Directors on the contribution of SemCAMS to a joint venture with KKR C$1,150
January 8, 2019 Closed Advised Blackstone Tactical Opportunities on its strategic minority investment in Annexus NA
January 7, 2019 Pending Advising ContourGlobal plc on its acquisition of Alpek S.A.B. de C.V.’s Mexican portfolio of cogeneration plants ~$800
January 7, 2019 Pending Advising Stackhouse Poland Group Limited on its sale to Arthur J. Gallagher & Co. NA
January 4, 2019 Closed
January 2019
Advised David’s Bridal on its consensual restructuring plan ~$800
January 3, 2019 Pending Advising Bristol-Myers Squibb Company on its acquisition of Celgene Corporation ~$90,000

** Equity Value